Drugs / ChloraPrep
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT03417661 | Jun 2018 → Jun 2019 | — | Gama Healthcare Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02578771 | Oct 2015 → Jan 2016 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03523962 | Aug 2018 → Mar 2023 | — | University of Maryland, Baltimore | Completed | Mixed |
| Phase 4 | NCT02017145 | Feb 2014 → Feb 2015 | — | Sanford Health | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03393819 | Oct 2014 → Jan 2016 | osteoarthritis, hip, prosthesis-related infectious disease | Lakehead University | Completed | No outcome recorded |
| Comparator or background therapy11 trials | ||||||
| Phase 1 | NCT02160587 Comparator | Jul → Oct 2014 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02160574 Comparator | Jun → Sep 2014 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT03155178 Comparator | Dec 2016 → Apr 2017 | — | Solventum US LLC | Completed | Missed primary |
| Phase 2 | NCT02296645 Comparator | Nov 2014 → Jan 2015 | — | Zurex Pharma, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02221232 Comparator | Aug → Oct 2014 | — | Zurex Pharma, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT03782103 Comparator | Jan → May 2019 | — | Zurex Pharma, Inc. | Completed | Met primary |
| Phase 3 | NCT02831816 Comparator | Aug 2016 → Aug 2017 | — | Zurex Pharma, Inc. | Completed | Met primary |
| Phase 3 | NCT02831998 Comparator | Jul 2016 → Apr 2017 | — | Zurex Pharma, Inc. | Completed | Met primary |
| Phase 3 | NCT02203591 Comparator | Jul 2014 → Mar 2015 | — | 3M | Completed | No outcome recorded |
| Phase 3 | NCT01968356 Comparator | Oct 2013 → Jan 2014 | — | Solventum US LLC | Terminated | No outcome recorded |
| Phase 4 | NCT01290978 Comparator | Feb → Mar 2010 | — | Solventum US LLC | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 17 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chloraprep | “Microbial skin flora on abdominal and groin sites in healthy volunteers were microbiologically sampled following randomization to either ZuraGard, a 2% chlorhexidine/70%...” PMID 32131912 ↗ Jun 2020 |
| Known as | ChloraPrep with Tint (Scrub Teal) | “ChloraPrep® with Tint (Scrub Teal®)” NCT01290978 ↗ |
| Modality | Other / unclassified | “The CHG intervention is an antiseptic solution comprised of 2% CHG in 70% isopropyl alcohol.” NCT03523962 ↗ |
| Route | Topical | “The application sites (subjects' backs) will be prepped with ChloraPrep according to manufacturer's instruction.” NCT01290978 ↗ |